Global Prosthetic Heart Valves Market 2018-2022
About Prosthetic Heart Valves
The prosthetic heart valves are the artificial valves that are made of either metal or animal issue. These valves mimic the function of the original valves in the patient after the successful implantation.
Technavio’s analysts forecast the Global Prosthetic Heart Valves Market 2018-2022 to grow at a CAGR of 12.38% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the prosthetic heart valves market. To calculate the market size, the report considers the revenue generated from the sales of products such as transcatheter heart valves, tissue heart valves, and mechanical heart valves.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Prosthetic Heart Valves Market 2018-2022
Technavio recognizes the following companies as the key players in the prosthetic heart valves market: Abbott, Boston Scientific, Edwards Lifesciences, LivaNova, Lepu Medical Technology, Medtronic
Commenting on the report, an analyst from Technavio’s team said: “Emergence of MRI-conditional heart valves will be a key driver for the market growth. Vendors are investing significantly in R&D activities to develop MRI-conditional heart valves. MRI-conditional heart valves imprve the visibility of the heart valve during the procedural examination.”
According to the report, the growing prevalence of heart-related disorders will be a key driver influencing the growth of this market. There is growing prevalence of chronic heart valve-related disorders such as cardio valvular diseases, and valvular and heart failure. Also, numerous heart disorders and arterial diseases are contributing to the demand for cardiac prosthetic devices.
Further, the report states that complications associated with prosthetic heart valve replacement will be a challenge to the market growth. Heart valve implantation has high rate of acute complications such as bleeding, infection, pneumonia, and blood clots that lead to heart attack, stroke, or lung disorders. Due to these serious complications with transcatheter and tissue valve replacement procedures and devices will restrain the market growth.
Abbott, Boston Scientific, Edwards Lifesciences, LivaNova, Lepu Medical Technology, Medtronic